United Therapeutics Corp (UTHR)
272.88
-3.62
(-1.31%)
USD |
NASDAQ |
May 24, 16:00
272.77
-0.11
(-0.04%)
After-Hours: 20:00
United Therapeutics Accounts Receivable (Quarterly): 307.30M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 307.30M |
December 31, 2023 | 278.90M |
September 30, 2023 | 258.60M |
June 30, 2023 | 272.70M |
March 31, 2023 | 134.50M |
December 31, 2022 | 220.40M |
September 30, 2022 | 231.70M |
June 30, 2022 | 173.40M |
March 31, 2022 | 170.50M |
December 31, 2021 | 198.70M |
September 30, 2021 | 212.80M |
June 30, 2021 | 173.40M |
March 31, 2021 | 141.10M |
December 31, 2020 | 157.40M |
September 30, 2020 | 152.30M |
June 30, 2020 | 172.00M |
March 31, 2020 | 149.60M |
December 31, 2019 | 151.40M |
September 30, 2019 | 183.60M |
June 30, 2019 | 181.00M |
March 31, 2019 | 159.80M |
December 31, 2018 | 175.70M |
September 30, 2018 | 215.20M |
June 30, 2018 | 251.30M |
March 31, 2018 | 211.10M |
Date | Value |
---|---|
December 31, 2017 | 297.10M |
September 30, 2017 | 251.80M |
June 30, 2017 | 273.90M |
March 31, 2017 | 188.00M |
December 31, 2016 | 214.50M |
September 30, 2016 | 224.60M |
June 30, 2016 | 238.10M |
March 31, 2016 | 194.80M |
December 31, 2015 | 192.80M |
September 30, 2015 | 179.64M |
June 30, 2015 | 169.21M |
March 31, 2015 | 156.15M |
December 31, 2014 | 162.29M |
September 30, 2014 | 139.90M |
June 30, 2014 | 212.90M |
March 31, 2014 | 131.77M |
December 31, 2013 | 126.30M |
September 30, 2013 | 130.64M |
June 30, 2013 | 131.56M |
March 31, 2013 | 101.35M |
December 31, 2012 | 116.63M |
September 30, 2012 | 108.95M |
June 30, 2012 | 98.58M |
March 31, 2012 | 89.15M |
December 31, 2011 | 88.68M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
134.50M
Minimum
Mar 2023
307.30M
Maximum
Mar 2024
196.06M
Average
177.20M
Median
Accounts Receivable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 28.44M |
Esperion Therapeutics Inc | 54.61M |
Liquidia Corp | 2.57M |
Vertex Pharmaceuticals Inc | 1.793B |
ANI Pharmaceuticals Inc | 172.42M |